Between April 2002 and July 2003, 20 patients with hematological malignancies or metastatic solid tumors received an RIC allo-SCT from an HLA identical sibling in a pilot study assessing the impact of ...

Allogeneic SCT was introduced in the treatment of multiple myeloma (MM) 25 years ago, yet its role remains controversial. Although allogeneic SCT is possibly the only curative treatment and can induce ...